Is Regeneron Pharmaceuticals (REGN) Still Attractive After Recent Share Price Strength?
If you’re questioning whether or not Regeneron Pharmaceuticals at round US$766 per share nonetheless gives worth, the reply relies on the way you take a look at what the market is pricing in in the present day. The inventory lately closed at US$766.02, with returns of two.7% over 7 days, 3.3% over 30 days, a…